Emcure Pharmaceuticals Limited has filed a regulatory disclosure under Regulation 30 of the SEBI Listing Regulations. The disclosure intimates the allotment of equity shares to employees pursuant to the exercise of stock options.
Key Quantitative Figures
- Number of Equity Shares Allotted: 70,000 (Seventy Thousand)
- Face Value per Share: ₹10/- (Rupees Ten only)
- Pre-allotment Issued and Paid-up Share Capital: 18,95,89,547 Equity Shares aggregating to ₹1,89,58,95,470/-
- Post-allotment Issued and Paid-up Share Capital: 18,96,59,547 Equity Shares aggregating to ₹1,89,65,95,470/-
- Increase in Share Capital: ₹7,00,000/- (70,000 shares × ₹10 face value)
Dates of Action
- Committee Approval Date: May 27, 2026
- Resolution Number: 01 of 2026-27 (passed by circulation)
Parties Involved
- Approving Authority: Nomination and Remuneration Committee of the Board of Directors
- Recipients: Eligible employees of the company
- Scheme: Emcure - Employee Stock Option Scheme 2013 (Emcure ESOS 2013)
Capital Structure Impact
The allotment has resulted in a minor increase of 0.037% in the company's issued and paid-up share capital. The new equity shares will rank pari passu in all aspects with the existing equity shares of the company.
Financial Impact
The transaction represents a cash inflow to the company from employees exercising their stock options, though the exercise price is not disclosed in this filing.